Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study — So-Ryoung Lee (2023) | RDL Network
Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study
Article 2023 en
Authors
SL
So-Ryoung Lee
EC
Eue‐Keun Choi
SP
Sang‐Hyun Park
Abstract
1 min read
Rivaroxaban was associated with lower risks of renal adverse outcomes than warfarin in Korean patients with AF.
Discussion(0)
No comments yet. Be the first to comment.